AXIM BIOTECHNOLOGIES, INC. (AXIM) › Total LiabilitiesAXIM BIOTECHNOLOGIES, INC. (AXIM) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $02011: $62.1K2014: $1.32M2015: $2.96M2016: $3.82M2017: $8.48M2018: $8.17M2019: $8.45M2020: $9.75M2021: $7.66M2022: $9.04M2023: $11.78M$11.78M2010Total Liabilities (USD)2023Fiscal YearTotal LiabilitiesChange YoY2023$11.78M+30.3%2022$9.04M+18.0%2021$7.66M-21.4%2020$9.75M+15.3%2019$8.45M+3.4%2018$8.17M-3.6%2017$8.48M+121.9%2016$3.82M+29.2%2015$2.96M+124.1%2014$1.32M—2011$62.1K—2010$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share